131 related articles for article (PubMed ID: 35891836)
1. The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome.
Kemanci A; Goren T; Uluturk M; Yilmaz A; Sabirli R; Ozen M; Seyit M; Oskay A; Koseler A; Turkcuer I
Cureus; 2022 Jun; 14(6):e26147. PubMed ID: 35891836
[TBL] [Abstract][Full Text] [Related]
2. Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y; Li P; Zhang J; Shi Y; Chen K; Yang J; Wu Y; Ye X
Medicine (Baltimore); 2016 Aug; 95(32):e4299. PubMed ID: 27512842
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptors gene polymorphisms and risk of restenosis and clinical events following coronary stenting.
Neugebauer P; Goldbergová-Pávková M; Kala P; Bocek O; Jerábek P; Poloczek M; Vytiska M; Parenica J; Mikulík R; Jarkovský J; Semrád B; Spinar J; Vasků A
Vnitr Lek; 2009 Dec; 55(12):1135-40. PubMed ID: 20070029
[TBL] [Abstract][Full Text] [Related]
4. Impact of the C1431T Polymorphism of the Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ) Gene on Fasted Serum Lipid Levels in Patients with Coronary Artery Disease.
Oladi M; Nohtani M; Avan A; Mirhafez SR; Tajbakhsh A; Ghasemi F; Asadi A; Elahdadi Salmani M; Mohammadi A; Hoseinzadeh L; Ferns GA; Ghayour Mobarhan M
Ann Nutr Metab; 2015; 66(2-3):149-154. PubMed ID: 25896411
[TBL] [Abstract][Full Text] [Related]
5. PPAR-alpha L162V and PGC-1 G482S gene polymorphisms, but not PPAR-gamma P12A, are associated with alcohol consumption in a Spanish Mediterranean population.
Francès F; Verdú F; Portolés O; Castelló A; Sorlí JV; Guillen M; Corella D
Clin Chim Acta; 2008 Dec; 398(1-2):70-4. PubMed ID: 18786524
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
7. Screening of Peroxisome Proliferator-Activated Receptors (PPARs) α, γ and α Gene Polymorphisms for Obesity and Metabolic Syndrome Association in the Multi-Ethnic Malaysian Population.
Chia PP; Fan SH; Say YH
Ethn Dis; 2015 Nov; 25(4):383-90. PubMed ID: 26673968
[TBL] [Abstract][Full Text] [Related]
8. PPAR-alpha L162V polymorphism in human hepatocellular carcinoma.
Koytak ES; Mizrak D; Bektaş M; Verdi H; Arslan Ergül A; Idilman R; Cinar K; Yurdaydin C; Ersõz S; Karayalçin K; Uzunalimoğlu O; Bozkaya H
Turk J Gastroenterol; 2008 Dec; 19(4):245-9. PubMed ID: 19119483
[TBL] [Abstract][Full Text] [Related]
9. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
[TBL] [Abstract][Full Text] [Related]
10. The dependence of serum interleukin-6 level on PPAR-alpha polymorphism in men with coronary atherosclerosis.
Skoczynska A; Dobosz T; Poreba R; Turczyn B; Derkacz A; Zoledziewska M; Jonkisz A; Lebioda A
Eur J Intern Med; 2005 Nov; 16(7):501-6. PubMed ID: 16275545
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease.
Brune S; Kölsch H; Ptok U; Majores M; Schulz A; Schlosser R; Rao ML; Maier W; Heun R
J Neural Transm (Vienna); 2003 Sep; 110(9):1041-50. PubMed ID: 12938026
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome.
Chae SJ; Kim JJ; Choi YM; Kim JM; Cho YM; Moon SY
Gynecol Obstet Invest; 2010; 70(1):1-7. PubMed ID: 20130411
[TBL] [Abstract][Full Text] [Related]
13. Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome.
Giandalia A; Pappalardo MA; Russo GT; Romeo EL; Alibrandi A; Di Bari F; Vita R; Cucinotta D; Benvenga S
J Clin Transl Endocrinol; 2018 Sep; 13():1-8. PubMed ID: 30013936
[TBL] [Abstract][Full Text] [Related]
14. The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Ding S; Liu L; Zhuge QC; Yu Z; Zhang X; Xie J; Hong W; Wang S; Yang Y; Chen B
Wien Klin Wochenschr; 2012 Oct; 124(19-20):671-7. PubMed ID: 22987045
[TBL] [Abstract][Full Text] [Related]
15. [Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome].
Luo YM; Wan XH; Jiang DQ; Kuang WY; Guo HB; Chen ZX; Wang HJ; Xie LH; Duan W
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):739-45. PubMed ID: 20021931
[TBL] [Abstract][Full Text] [Related]
16. Biochemical investigation of rs1801282 variations in PPAR-γ gene and its correlation with risk factors of diabetes mellitus in coronary artery disease.
Rehman K; Jabeen K; Awan FR; Hussain M; Saddique MA; Akash MSH
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1517-1529. PubMed ID: 32416637
[TBL] [Abstract][Full Text] [Related]
17. Effect of the peroxisome proliferator-activated receptor-gamma C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scallissi N; Speranza AC; Gomes S; Hirata MH
J Endocrinol Invest; 2005 Feb; 28(2):129-36. PubMed ID: 15887858
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy.
Yao Q; Nordfors L; Axelsson J; Heimbürger O; Qureshi AR; Báràny P; Lindholm B; Lönnqvist F; Schalling M; Stenvinkel P
Atherosclerosis; 2005 Sep; 182(1):105-11. PubMed ID: 16115480
[TBL] [Abstract][Full Text] [Related]
19. Enhanced peroxisome proliferator-activated receptor-gamma expression in monocyte/macrophages from coronary artery disease patients and possible gender differences.
Amoruso A; Bardelli C; Fresu LG; Palma A; Vidali M; Ferrero V; Ribichini F; Vassanelli C; Brunelleschi S
J Pharmacol Exp Ther; 2009 Nov; 331(2):531-8. PubMed ID: 19644041
[TBL] [Abstract][Full Text] [Related]
20. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
Zeng XL; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
